SCHEMBL1871308

SCHEMBL1871308

O=C(N[S+]([O-])c1cnc(OCC2CCOCC2)c(Cl)c1)c1ccc(N2CCN(CC3=C(c4ccc(Cl)cc4)CCC4(CCN(C(CF)CF)CC4)C3)CC2)cc1Oc1cnc2[nH]ccc2c1

nearest known ligand 0.82

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 20/20 0.82

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1702804 0.90 BCL2 (1.00) BCL2
SCHEMBL1811037 0.84 BCL2 (0.90) BCL2
SCHEMBL1701578 0.83 BCL2 (0.70) BCL2
SCHEMBL1868297 0.83 BCL2 (0.81) BCL2
SCHEMBL1869790 0.82 BCL2 (0.84) BCL2
SCHEMBL19424395 0.82 BCL2 (0.82) BCL2
SCHEMBL1701823 0.82 BCL2 (0.68) BCL2
SCHEMBL30313845 0.81 BCL2 (0.82) BCL2
SCHEMBL1701414 0.81 BCL2 (0.82) BCL2
SCHEMBL1869170 0.78 BCL2 (0.82) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2435432-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Abbott Laboratories (US) 2012-04-04 — — EP disclosed
WO-2010138588-A9 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2011-05-05 — — WO disclosed
WO-2010138588-A2 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES ABBOTT LABORATORIES (US) 2010-12-02 — — WO disclosed
Send feedback